Publications
-
Lecture halls without lectures--a proposal for medical education.
Prober CG,
Heath C.
N Engl J Med.
2012;
366
(18):
1657-9
-
Commentary: to genotype or not to genotype? Addressing the debate through the development of a genomics and personalized medicine curriculum.
Salari K,
Pizzo PA, Prober CG.
Acad Med.
2011;
86
(8):
925-7
-
Decisions, decisions: how program diversity influences residency program choice.
Ku MC,
Li YE, Prober C, Valantine H, Girod SC.
J Am Coll Surg.
2011;
213
(2):
294-305
-
Human herpesvirus 6.
Prober CG,
Adv Exp Med Biol.
2011:
697
87-90
-
Principles & Practice of Pediatric Infectious Diseases
Long SS, Pickering LK, Prober CG (Editors),
Principles & Practice of Pediatric Infectious Diseases.
2008
-
Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes.
Brown EL,
Gardella C, Malm G, Prober CG, Forsgren M, Krantz EM, Arvin AM, Yasukawa LL, Mohan K, Brown Z, Corey L, Wald A.
Acta Obstet Gynecol Scand.
2007;
86
(5):
523-9
-
Treatment of naturally acquired common colds with zinc: a structured review.
Caruso TJ,
Prober CG, Gwaltney JM.
Clin Infect Dis.
2007;
45
(5):
569-74
-
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes.
Brown EL,
Morrow R, Krantz EM, Arvin AM, Prober CG, Yasukawa LL, Corey L, Wald A.
Am J Obstet Gynecol.
2006;
195
(1):
115-20
-
Sixth disease and the ubiquity of human herpesviruses.
Prober C,
N Engl J Med.
2005;
352
(8):
753-5
-
Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus.
Enright AM,
Prober CG.
Pediatr Clin North Am.
2004;
51
(4):
889-908, viii
-
New antivirals and antiviral resistance.
Prober CG,
Adv Exp Med Biol.
2004:
549
9-12
-
Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
Enright AM,
Prober C.
Herpes.
2003;
10
(2):
32-7
-
Congenital cytomegalovirus (CMV) infections: hats off to Alabama.
Prober CG,
Enright AM.
J Pediatr.
2003;
143
(1):
4-6
-
Antiviral therapy for influenza virus infections.
Prober CG,
Semin Pediatr Infect Dis.
2002;
13
(1):
31-9
-
Neonatal herpes infection: diagnosis, treatment and prevention.
Enright AM,
Prober CG.
Semin Neonatol.
2002;
7
(4):
283-91
-
Antiviral agents effective against herpesviruses.
Dekker CL,
Prober CG.
Curr Clin Top Infect Dis.
2001:
21
271-301
-
Management of the neonate whose mother received suppressive acyclovir therapy during late pregnancy.
Prober CG,
Pediatr Infect Dis J.
2001;
20
(1):
90-1
-
Pediatric uses of valacyclovir, penciclovir and famciclovir.
Dekker CL,
Prober CG.
Pediatr Infect Dis J.
2001;
20
(11):
1079-81
-
Prevention of hepatitis B in adolescents.
Abramson JS,
Baker CJ, Fisher MC, Gerber MA, Meissner HC, Murray DL, Overturf GD, Prober CG, Rennels MB, Saari TN, Weiner LB, Whitley RJ, Pickering LK.
Pediatrics.
2001;
108
(6):
1392
-
Technical report: precautions regarding the use of aerosolized antibiotics. Committee on Infectious Diseases and Committee on Drugs.
Prober CG,
Walson PD, Jones J.
Pediatrics.
2000;
106
(6):
E89
-
Advances in prevention of respiratory syncytial virus infections.
Prober CG,
Sullender WM.
J Pediatr.
1999;
135
(5):
546-58
-
Possible association of intussusception with rotavirus vaccination. American Academy of Pediatrics. Committee on Infectious Diseases.
Abramson JS,
Baker CJ, Fisher MC, Gerber MA, Meissner HC, Murray DL, Overturf GD, Prober CG, Rennels MB, Saari TN, Weiner LB, Whitley RJ.
Pediatrics.
1999;
104
(3 Pt 1):
575
-
Posttraumatic invasive Aspergillus fumigatus wound infection.
Gettleman LK,
Shetty AK, Prober CG.
Pediatr Infect Dis J.
1999;
18
(8):
745-7
-
Cephalosporins: an update.
Prober CG,
Pediatr Rev.
1998;
19
(4):
118-27
-
Encephalitis. Identifying the specific cause is key to effective management.
Gutierrez KM,
Prober CG.
Postgrad Med.
1998;
103
(3):
123-5, 129-30, 140-3
-
Acyclovir therapy in a steroid recipient with varicella.
Prober CG,
Pediatr Infect Dis J.
1997;
16
(11):
1095-6
-
Bacterial resistance and the dilemma of antibiotic usage.
Prober CG,
West J Med.
1997;
166
(5):
337-8
-
Genital herpes during pregnancy: inability to distinguish primary and recurrent infections clinically.
Hensleigh PA,
Andrews WW, Brown Z, Greenspoon J, Yasukawa L, Prober CG.
Obstet Gynecol.
1997;
89
(6):
891-5
-
Herpes simplex virus type 2--a persistent problem.
Arvin AM,
Prober CG.
N Engl J Med.
1997;
337
(16):
1158-9
-
Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer.
Prober CG,
Wang EE.
Pediatrics.
1997;
99
(3):
472-5
-
Antibiotic update: overview.
Prober CG,
Pediatr Ann.
1996;
25
(11):
604, 606-7
-
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Kimberlin DW,
Lakeman FD, Arvin AM, Prober CG, Corey L, Powell DA, Burchett SK, Jacobs RF, Starr SE, Whitley RJ.
J Infect Dis.
1996;
174
(6):
1162-7
-
Early diagnosis and management of herpes simplex encephalitis.
Prober CG,
Enzmann DR.
Pediatr Infect Dis J.
1996;
15
(4):
387-8
-
Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population.
Huerta K,
Berkelhamer S, Klein J, Ammerman S, Chang J, Prober CG.
J Adolesc Health.
1996;
18
(6):
384-6
-
Herpesvirus infections of the vulva.
Nader SN,
Prober CG.
Semin Dermatol.
1996;
15
(1):
8-16
-
Pediatric resident training in a school environment. A prescription for learning.
Zenni EA,
Sectish TC, Martin BN, Prober CG.
Arch Pediatr Adolesc Med.
1996;
150
(6):
632-7
-
Pharmacokinetic optimisation of the treatment of septic arthritis.
Hamed KA,
Tam JY, Prober CG.
Clin Pharmacokinet.
1996;
31
(2):
156-63
-
T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
Carmack MA,
Yasukawa LL, Chang SY, Tran C, Saldana F, Arvin AM, Prober CG.
J Infect Dis.
1996;
174
(5):
899-906
-
The role of steroids in the management of children with bacterial meningitis.
Prober CG,
Pediatrics.
1995;
95
(1):
29-31
-
Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay.
Arvin AM,
Prober CG.
Infect Agents Dis.
1993;
2
(6):
375-82
-
Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs.
Randolph AG,
Washington AE, Prober CG.
JAMA.
1993;
270
(1):
77-82
-
Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2.
Boucher FD,
Yasukawa LL, Kerns K, Kastelein M, Arvin AM, Prober CG.
Clin Diagn Virol.
1993;
1
(1):
29-38
-
Fever and infection in the age since Wunderlich.
Carmack MA,
Prober CG.
J Infect Dis.
1993;
167
(5):
1258-9
-
Herpetic vaginitis in 1993.
Prober CG,
Clin Obstet Gynecol.
1993;
36
(1):
177-87
-
Neonatal herpes: vexing dilemmas and reasons for hope.
Carmack MA,
Prober CG.
Curr Opin Pediatr.
1993;
5
(1):
21-8
-
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group.
Balfour HH,
Rotbart HA, Feldman S, Dunkle LM, Feder HM, Prober CG, Hayden GF, Steinberg S, Whitley RJ, Goldberg L.
J Pediatr.
1992;
120
(4 Pt 1):
627-33
-
Current antibiotic therapy of community-acquired bacterial infections in hospitalized children: bone and joint infections.
Prober CG,
Pediatr Infect Dis J.
1992;
11
(2):
156-9
-
Herpes simplex virus infections: the genital tract and the newborn.
Arvin AM,
Prober CG.
Pediatr Rev.
1992;
13
(3):
107-12
-
Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy.
Kulhanjian JA,
Soroush V, Au DS, Bronzan RN, Yasukawa LL, Weylman LE, Arvin AM, Prober CG.
N Engl J Med.
1992;
326
(14):
916-20
-
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
Koropchak CM,
Graham G, Palmer J, Winsberg M, Ting SF, Wallace M, Prober CG, Arvin AM.
J Infect Dis.
1992;
165
(1):
188
-
Potential of population pharmacokinetics to reduce the frequency of blood sampling required for estimating kinetic parameters in neonates.
Collart L,
Blaschke TF, Boucher F, Prober CG.
Dev Pharmacol Ther.
1992;
18
(1-2):
71-80
-
Prophylactic fluconazole and Candida krusei infections.
Tam JY,
Blume KG, Prober CG.
N Engl J Med.
1992;
326
(13):
891; author reply 892-3
-
Respiratory syncytial virus and ribavirin: quo vadis?
Carmack MA,
Prober CG.
Infect Agents Dis.
1992;
1
(2):
99-107
-
The management of pregnancies complicated by genital infections with herpes simplex virus.
Prober CG,
Corey L, Brown ZA, Hensleigh PA, Frenkel LM, Bryson YJ, Whitley RJ, Arvin AM.
Clin Infect Dis.
1992;
15
(6):
1031-8
-
The impact of respiratory viral infections in patients with cystic fibrosis.
Prober CG,
Clin Rev Allergy.
1991 Spring-Summer;
9
(1-2):
87-102
-
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
Whitley R,
Arvin A, Prober C, Burchett S, Corey L, Powell D, Plotkin S, Starr S, Alford C, Connor J.
N Engl J Med.
1991;
324
(7):
444-9
-
A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.
Smith DW,
Frankel LR, Mathers LH, Tang AT, Ariagno RL, Prober CG.
N Engl J Med.
1991;
325
(1):
24-9
-
Cryptococcus infection in a nine-year-old child with hemophilia and the acquired immunodeficiency syndrome.
Ting SF,
Glader BE, Prober CG.
Pediatr Infect Dis J.
1991;
10
(1):
76-7
-
Medical management of newborns and infants born to human immunodeficiency virus-seropositive mothers.
Prober CG,
Gershon AA.
Pediatr Infect Dis J.
1991;
10
(9):
684-95
-
Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
Frenkel LM,
Brown ZA, Bryson YJ, Corey L, Unadkat JD, Hensleigh PA, Arvin AM, Prober CG, Connor JD.
Am J Obstet Gynecol.
1991;
164
(2):
569-76
-
Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Whitley R,
Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A.
N Engl J Med.
1991;
324
(7):
450-4
-
The risk of dexamethasone in pregnant women with a history of recurrent genital herpes.
Prober CG,
Pediatr Infect Dis J.
1991;
10
(1):
82-3
-
A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy.
Boucher FD,
Yasukawa LL, Bronzan RN, Hensleigh PA, Arvin AM, Prober CG.
Pediatr Infect Dis J.
1990;
9
(7):
499-504
-
Consensus: varicella-zoster infections in pregnancy and the perinatal period.
Prober CG,
Gershon AA, Grose C, McCracken GH, Nelson JD.
Pediatr Infect Dis J.
1990;
9
(12):
865-9
-
Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation.
Cohen P,
Collart L, Prober CG, Fischer AF, Blaschke TF.
Pediatr Infect Dis J.
1990;
9
(8):
562-6
-
Herpes simplex virus infections.
Arvin AM,
Prober CG.
Pediatr Infect Dis J.
1990;
9
(10):
765-7
-
The use of antibiotics in neonates weighing less than 1200 grams.
Prober CG,
Stevenson DK, Benitz WE.
Pediatr Infect Dis J.
1990;
9
(2):
111-21
-
Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery.
Hardy DA,
Arvin AM, Yasukawa LL, Bronzan RN, Lewinsohn DM, Hensleigh PA, Prober CG.
J Infect Dis.
1990;
162
(5):
1031-5
-
Genital herpes and the pregnant woman.
Prober CG,
Arvin AM.
Curr Clin Top Infect Dis.
1989:
10
1-26
-
Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
Kohl S,
West MS, Prober CG, Sullender WM, Loo LS, Arvin AM.
J Infect Dis.
1989;
160
(5):
770-6
-
Vancomycin pharmacokinetics in very low birth weight neonates.
Leonard MB,
Koren G, Stevenson DK, Prober CG.
Pediatr Infect Dis J.
1989;
8
(5):
282-6
-
Pharmacokinetics and adverse effects of amphotericin B in infants and children.
Koren G,
Lau A, Klein J, Golas C, Bologa-Campeanu M, Soldin S, MacLeod SM, Prober C.
J Pediatr.
1988;
113
(3):
559-63
-
Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
Sullender WM,
Yasukawa LL, Schwartz M, Pereira L, Hensleigh PA, Prober CG, Arvin AM.
J Infect Dis.
1988;
157
(1):
164-71
-
Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.
Prober CG,
Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM.
N Engl J Med.
1988;
318
(14):
887-91
-
False positivity of Legionella serology in patients with cystic fibrosis.
Wang EE,
Manson B, Corey M, Bernard K, Prober CG.
Pediatr Infect Dis J.
1987;
6
(3):
256-9
-
Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
Prober CG,
Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM.
N Engl J Med.
1987;
316
(5):
240-4
-
Perinatal viral infections.
Prober CG,
Arvin AM.
Eur J Clin Microbiol.
1987;
6
(3):
245-61
-
Recurrent urethritis associated with Ureaplasma urealyticum in a prepubertal boy.
Shawn DH,
Quinn PA, Prober C, Jadavji T.
Pediatr Infect Dis J.
1987;
6
(7):
687-8
-
Vancomycin pharmacokinetics and dose recommendations for preterm infants.
James A,
Koren G, Milliken J, Soldin S, Prober C.
Antimicrob Agents Chemother.
1987;
31
(1):
52-4
-
Primary osteomyelitis caused by coagulase-negative staphylococci.
Paley D,
Moseley CF, Armstrong P, Prober CG.
J Pediatr Orthop.
1986 Sep-Oct;
6
(5):
622-6
-
Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.
Arvin AM,
Hensleigh PA, Prober CG, Au DS, Yasukawa LL, Wittek AE, Palumbo PE, Paryani SG, Yeager AS.
N Engl J Med.
1986;
315
(13):
796-800
-
Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections.
Jadavji T,
Cheung R, Bannatyne RM, Prober CG.
CMAJ.
1986;
135
(4):
328-31
-
Sequelae of acute bacterial meningitis in children treated for seven days.
Jadavji T,
Biggar WD, Gold R, Prober CG.
Pediatrics.
1986;
78
(1):
21-5
-
The value of skin biopsies in febrile, neutropenic, immunocompromised children.
Allen U,
Smith CR, Prober CG.
Am J Dis Child.
1986;
140
(5):
459-61
-
Persistent fever and subdural effusions.
Prober CG,
Biggar WD.
Pediatr Infect Dis.
1985 Mar-Apr;
4
(2):
211-2
-
Brain abscesses in infants and children.
Jadavji T,
Humphreys RP, Prober CG.
Pediatr Infect Dis.
1985 Jul-Aug;
4
(4):
394-8
-
An unusual case of intracranial suppuration.
Prober CG,
Bachrach LK, Humphreys RP, Hendrick BE, Mehren KG, Rapley WA.
Pediatr Infect Dis.
1985 Jan-Feb;
4
(1):
101-3
-
Dactylitis in a child with sickle cell trait.
Jadavji T,
Prober CG.
Can Med Assoc J.
1985;
132
(7):
814-5
-
Effect of rifampin on chloramphenicol levels.
Prober CG,
N Engl J Med.
1985;
312
(12):
788-9
-
Treatment of bacterial infections in the neonate.
Prober CG,
Clin Invest Med.
1985;
8
(4):
368-70
-
Systemic tinea versicolor, or how far can furfur go?
Prober CG,
Ein SH.
Pediatr Infect Dis.
1984 Nov-Dec;
3
(6):
592
-
The management of central intravenous catheter infections.
Wang EE,
Prober CG, Ford-Jones L, Gold R.
Pediatr Infect Dis.
1984 Mar-Apr;
3
(2):
110-3
-
Aminoglycoside-related nephrotoxicity in the premature newborn.
Rajchgot P,
Prober CG, Soldin S, Perlman M, Good F, Harding E, Klein J, MacLeod S.
Clin Pharmacol Ther.
1984;
35
(3):
394-401
-
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.
Wang EE,
Prober CG, Manson B, Corey M, Levison H.
N Engl J Med.
1984;
311
(26):
1653-8
-
In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae.
Jadavji T,
Prober CG, Cheung R.
Antimicrob Agents Chemother.
1984;
26
(1):
91-3
-
Open lung biopsy in immunocompromised children with pulmonary infiltrates.
Prober CG,
Whyte H, Smith CR.
Am J Dis Child.
1984;
138
(1):
60-3
-
Prophylactic sulfamethoxazole and trimethoprim in ventriculoperitoneal shunt surgery. A double-blind, randomized, placebo-controlled trial.
Wang EE,
Prober CG, Hendrick BE, Hoffman HJ, Humphreys RP.
JAMA.
1984;
251
(9):
1174-7
-
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
Isles A,
Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H.
J Pediatr.
1984;
104
(2):
206-10
-
Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981.
Corey M,
Allison L, Prober C, Levison H.
J Infect Dis.
1984;
149
(2):
283
-
Cefoperazone: a comparative in vitro Canadian study of 1743 pathogens, Canadian Infectious Disease Study Group.
Harding GK,
Prober CG, Delage G, Bergeron MG, Mendelson J, Marcoux JA, Dias NW.
Can J Public Health.
1983 Nov-Dec;
74
(6):
409-13
-
Amikacin doses in very low birthweight newborns.
Prober CG,
Rajchgot P.
Pediatr Pharmacol (New York).
1983;
3
(2):
125-6
-
Chloramphenicol in the newborn infant.
Rajchgot P,
Prober CG, Soldin S, Golas C, Good F, Harding E, MacLeod S.
Prog Clin Biol Res.
1983:
135
421-5
-
Chloramphenicol pharmacokinetics in the newborn.
Rajchgot P,
Prober C, Soldin S, Golas C, Good F, Harding L, MacLeod S.
Dev Pharmacol Ther.
1983;
6
(5):
305-14
-
Immunologic responses of children to serious infections with Streptococcus pneumoniae.
Prober CG,
Frayha H, Klein M, Schiffman G.
J Infect Dis.
1983;
148
(3):
427-35
-
Impact of chloramphenicol use on bacterial resistance in a neonatal intensive care unit.
Prober CG,
Rajchgot P, Bannatyne RM, Cheung R, Good F, Harding E, MacLeod S.
Lancet.
1983;
2
(8342):
158
-
Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography.
Golas CL,
Prober CG, MacLeod SM, Soldin SJ.
J Chromatogr.
1983;
278
(2):
387-95
-
The high performance liquid chromatographic measurement of chloramphenicol and its succinate esters in serum.
Soldin SJ,
Golas C, Rajchgot P, Prober CG, MacLeod SM.
Clin Biochem.
1983;
16
(3):
171-7
-
Toward optimization of therapy in the neonate.
Rajchgot P,
Prober CG, Soldin SJ, Good F, Harding E, Golas C, MacLeod S.
Clin Pharmacol Ther.
1983;
33
(5):
551-5
-
Varicella zoster virus antibody titers before and after administration of zoster immune globulin to neonates in an intensive care nursery.
Wang EE,
Prober CG, Arvin AM.
J Pediatr.
1983;
103
(1):
113-4
-
Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole.
Wang EE,
Prober CG.
J Antimicrob Chemother.
1983;
11
(4):
385-9
-
Oral antibiotic therapy for bone and joint infections.
Prober CG,
Pediatr Infect Dis.
1982 Jan-Feb;
1
(1):
8-10
-
Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study.
Prober CG,
Kirk LE, Keeney RE.
J Pediatr.
1982;
101
(4):
622-5
-
Fever in a newborn.
Prober CG,
Smith CR, Middleton PJ, Silver MM.
Can Med Assoc J.
1982;
127
(11):
1085-90
-
Haemophilus influenzae type b in a nursery school: the value of biotyping.
Prober CG,
Ipp MM, Bannatyne RM.
Pediatrics.
1982;
69
(2):
215-8
-
Initiation of chloramphenicol therapy in the newborn infant.
Rajchgot P,
Prober CG, Soldin S, Golas C, Good F, Harding E, MacLeod S.
J Pediatr.
1982;
101
(6):
1018-21
-
Eikenella corrodens empyema in children.
St John MA,
Belda AA, Matlow A, Prober CG.
Am J Dis Child.
1981;
135
(5):
415-7
-
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
Yeager AS,
Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG.
J Pediatr.
1981;
98
(2):
281-7
-
Side effects of cloxacillin in infants and children.
St John MA,
Prober CG.
Can Med Assoc J.
1981;
125
(5):
458-60
-
The effect of chronologic age on the serum concentrations of amikacin in sick term and premature infants.
Prober CG,
Yeager AS, Arvin AM.
J Pediatr.
1981;
98
(4):
636-40
-
Antibiotic abuse: spare the child.
Prober CG,
Gold R.
Can Med Assoc J.
1980;
122
(1):
7-8
-
Comparison of a micromethod for performance of the serum bactericidal test with the standard tube dilution method.
Prober CG,
Dougherty SS, Vosti KL, Yeager AS.
Antimicrob Agents Chemother.
1979;
16
(1):
46-8
-
Storage and transport of cultures for Herpes simplex virus, type 2.
Yeager AS,
Morris JE, Prober CG.
Am J Clin Pathol.
1979;
72
(6):
977-9
-
The white cell ratio in the very low birth weight infant.
Prober CG,
Stevenson DK, Neu J, Johnson JD.
Clin Pediatr (Phila).
1979;
18
(8):
481-6
-
Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis.
Prober CG,
Yeager AS.
J Pediatr.
1979;
95
(1):
131-5
-
Yersinia pseudotuberculosis septicemia.
Prober CG,
Tune B, Hoder L.
Am J Dis Child.
1979;
133
(6):
623-4
Navigation for This Section: Pediatrics
Find a Researcher
Help